Studies demonstrated that AhR activation, induced by tryptophan metabolism and Kyn accumulation, enhances tumor cell proliferation and invasion in patient-derived glioma samples [17] and human GBM cell lines [18], findings that highlight the AhR as a promising therapeutic target for glioblastoma treatment. Here, AHR is linked to central nervous system cancer.